Skip to main content

Find Clinical Trials

Home
Conditions
Diabetes

Clinical trial condition

Diabetes

Explore clinical trials studying Diabetes. Study availability and eligibility vary by location and protocol.

2,489 public trials 175 recruiting studies

Refine in advanced search Browse all conditions

Diabetes trial results

Completed

A Trial Comparing the Effect of NN1250 After Different Routes of Injection in Healthy Subjects

NCT01151072

Conditions: Diabetes, Diabetes Mellitus, Endocrine System Diseases, +4 more
Locations: Novo Nordisk Investigational Site Neuss, Germany

View Trial Details

Completed

A Trial Investigating the Pharmacokinetic (Mode of Action in the Body) and Safety Profiles of NN1250 (Insulin Degludec) in Subjects With Various Degrees of Impaired Liver Function and in Subjects With Normal Liver Function

NCT00976326

Conditions: Diabetes, Diabetes Mellitus, Endocrine System Diseases, +4 more
Locations: Novo Nordisk Investigational Site Bratislava, Slovakia

View Trial Details

Completed

A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Children With Type 1 Diabetes

NCT01435642

Conditions: Autoimmune Diseases, Diabetes, Diabetes Mellitus, +6 more
Locations: Novo Nordisk Investigational Site Blida, Algeria

View Trial Details

Completed

A Trial Evaluating the Blood Glucose-lowering Effect of NN1250 in Subjects With Type 2 Diabetes

NCT01154881

Conditions: Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations: Novo Nordisk Investigational Site Neuss, Germany

View Trial Details

Completed

A Trial Investigating the Effect of NN1250 in Japanese Subjects With Type 1 Diabetes

NCT01135927

Conditions: Autoimmune Diseases, Diabetes, Diabetes Mellitus, +6 more
Locations: Novo Nordisk Investigational Site Tokyo, Japan

View Trial Details

Completed

A Trial Investigating the Concentration in the Blood of NN1250 in Children, Adolescents and Adults With Type 1 Diabetes

NCT01030926

Conditions: Autoimmune Diseases, Diabetes, Diabetes Mellitus, +6 more
Locations: Novo Nordisk Investigational Site Hanover, Germany

View Trial Details

Completed

A Trial Comparing Sequential Addition of Insulin Aspart Versus Further Dose Increase With Insulin Degludec/Liraglutide in Subjects With Type 2 Diabetes Mellitus, Previously Treated With Insulin Degludec/Liraglutide and Metformin and in Need of Further Intensification

NCT02100475

Conditions: Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations: Novo Nordisk Investigational Site Fresno, California, United States

Novo Nordisk Investigational Site Fort Lauderdale, Florida, United States

Novo Nordisk Investigational Site Gurnee, Illinois, United States

Novo Nordisk Investigational Site Lexington, Kentucky, United States

View all 60 locations

View Trial Details

Completed

Comparison of Hypoglycaemic Response Between NN1250 and Insulin Glargine in Type 1 Diabetics

NCT01002768

Conditions: Autoimmune Diseases, Diabetes, Diabetes Mellitus, +6 more
Locations: Novo Nordisk Investigational Site Graz, Austria

View Trial Details

Completed

A Trial Investigating the Effect of NN1250 in Young and Elderly Subjects With Type 1 Diabetes

NCT00964418

Conditions: Autoimmune Diseases, Diabetes, Diabetes Mellitus, +6 more
Locations: Novo Nordisk Investigational Site Graz, Austria

View Trial Details

Completed

A Trial Investigating the NN1250 Concentration-time Curve in Subjects With Various Degrees of Renal Impairment and in Subjects With Normal Renal Function

NCT01006057

Conditions: Diabetes, Diabetes Mellitus, Endocrine System Diseases, +4 more
Locations: Novo Nordisk Investigational Site Budapest, Hungary

View Trial Details